Pelargonium sidoides is a medicinal plant native to South Africa. Its common names include Umckaloabo and South African Geranium. Root extract of Pelargonium sidoides is used as cold and flu remedies, also referred to as Kaloba, Umcka and Zucol2
- Belongs to Geraniaceae family (Geranium)
- Heart-shaped leaves, red narrow flowers
- Root is the part used for medicinal properties
Pelargonium sidoides properties:
- Shortens duration of infection1
- Reduces severity of infection1
Can assist your body with:*
- Bronchitis, sinusitis, tonsillitis and ear infections.(Upper and lower respiratory infections)5,6
- Immune modulation – assistance get over infections quicker3,6
- Acute infection – take for at least five days1-4
*Efficacy of support may vary between users
Brown D. Extract Pelargonium sidoides (EPs 7630): Alternative Treatment of Acute Upper Respiratory Tract Infections. Nat Med J 2009; 1(14): 1-6.
Roxas M, Jurenka J. Colds and Influenza: A review of diagnosis and conventional, botanical, and nutritional considerations. Alt Med Rev 2007; 12(1): 25-48.
Matthys H, Kamin W.EPs 7630, a Herbal Drug Preparation for Treating Acute Bronchitis in Children and Adults, Approaches to Bronchitis, Prof. Marianna GaÃ§a (Ed.), ISBN: 978-953-307-770-3, InTech; 2011. DOI: 10.5772/20515. Available from: http://www.intechopen.com/books/approaches-to-bronchitis/eps-7630-a-herbal-drug-preparation-for-treating-acute-bronchitis-in-children-and-adults
Lizogub VG, Riley DS, Heger M. Efficacy of a pelargonium sidoides preparation in patients with the common cold: a randomized, double blind, placebo-controlled clinical trial. Explore 2007; 3(6): 573-584.
Matthys H, Eisebitt R, Seith B, et al. Efficacy and safety of an extract of Pelargonium sidoides (EPs 7630) in adults with acute bronchitis. A randomised, double-blind, placebo-controlled trial. Phytomedicine 2003; 10(Supplement IV): 7-17.
Bereznoy VV, Riley DS, Wassmer G, et al. Efficacy of extract of Pelargonium sidoides in children with acute non-group A beta-hemolytic streptococcus tonsillopharyngitis: a randomized, double-blind, placebo-controlled trial. Altern Ther Health Med 2003; 9(5): 68-79.